Illumina CEO Sold $3.3M Worth of Company Stock Since Start of 2006 | GenomeWeb
NEW YORK (GenomeWeb News) - Illumina CEO Jay Flatley sold 2,500 shares of the company's stock at $35.04 apiece for total proceeds of $87,600 on Aug. 10, according to documents filed with the Securities and Exchange Commission on Monday.
He sold 14,000 shares this month before last week's transaction for total proceeds of $515,466. He currently owns 647,998 shares of Ilumina stock.
Shares in Illumina were down 6.8 percent, or $2.34, to $32.09 in mid-afternoon trading today. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.